EOSC4Cancer
A European-wide foundation to accelerate Data-driven Cancer Research.
HORIZON Research and Innovation Actions
EOSC4Cancer is funded by the European Union’s Horizon Europe research and innovation actions under grant agreement No 101058427
01/09/2022 – 28/02/2025 (30 months)
Barcelona Supercomputing Center (Centro Nacional de Supercomputación)
VIEW PARTNERS >
Academisch Ziekenhuis Groningen, Netherlands
Albert-Ludwigs-Universitaet Freiburg, Germany
Barcelona Supercomputing Center – Centro Nacional De Supercomputación, Spain
Biobanks And Biomolecular Resources Research Infrastructure Consortium (BBMRI-ERIC), Austria
Centre National De La Recherche Scientifique CNRS, France
Consiglio Nazionale Delle Ricerche, Italy
CSC – Tieteen Tietotekniikan Keskus Oy, Finland
Deutsches Krebsforschungszentrum Heidelberg, Germany
EATRIS ERIC, Netherlands
ECRIN European Clinical Research Infrastructure Network, France
Empirica Gesellschaft Fur Kommunikations Und Technologieforschung mbH, Germany
Erasmus Universitair Medisch Centrum Rotterdam, Netherlands
Ethniko Kentro Erevnas Kai Technologikis Anaptyxis, Greece
EURO-BIOIMAGING ERIC, Finland
European Cancer Patient Coalition, Belgium
European Infrastructure of Open Screening Platforms for Chemical Biology European Research Infrastucture Consortium (EU-OPENSCREEN ERIC), Germany
European Molecular Biology Laboratory, Germany
Fundacio Centre De Regulacio Genomica, Spain
Fundacio Institut de Recerca Biomedica (IRB Barcelona), Spain
Fundacio Privada Institut D’investigacio Oncologica De Vall-Hebron (VHIO), Spain
Fundación Sector Público Estatal Centro Nacional Investigaciones Oncológicas Carlos III, Spain
Infrafrontier GmbH, Germany
INSTRUCT-ERIC, United Kingdom
Karolinska Institutet, Sweden
Masarykova Univerzita, Czech Republic
Stichting DTL Projects, Netherlands
Stichting Het Nederlands Kanker Instituutantoni van Leeuwenhoek Ziekenhuis, Netherlands
Stichting Lygature, Netherlands
The University of Manchester, United Kingdom
Universita degli Studi di Torino, Italy
Universite de Bordeaux, France
Universitetet I Oslo, Norway
Univerzita Palackeho V Olomouci, Czech Republic
Ustav Molekularni Genetiky Akademie Ved Ceske Republiky Verejna Vyzkumna Instituce, Czech Republic
Why it matters
EOSC4Cancer brings together a comprehensive consortium of cancer research centres, research infrastructures, leading research groups, hospitals and supercomputing centres from 14 European countries. To make the developments sustainable, these will be offered as part of the research infrastructures partners services portfolio, in connection with the EOSC ecosystem and to serve the
European Cancer Mission, which will be possible via the engagement with large international coalitions, e.g. ICGC-Argo, GA4GH, 1+MG/B1MG, Cancer Core Europe, European Cancer Information System, European Network of Cancer Registries, Innovative Partnership for Action Against Cancer Joint Action and patients/survivors associations.
What ECPC does
ECPC will ensure the dialogue with the patients regarding the shape of the outcomes and lines of the project. Help to identify the challenges related to cancer data services and the patients’ needs. ECPC will contribute to enforce the patient engagement and improve the trust, transparency and bias related to AI use in cancer diagnose and treatment.
This project has received funding from the European Union’s HORIZON Research and Innovation Actions under grant agreement No 101058427